Literature DB >> 28551770

Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers.

Holly Etchegary1, Elizabeth Dicks2, Laura Tamutis3, Lesa Dawson4.   

Abstract

Lynch syndrome (LS) is a genetic condition conferring an elevated risk of gastrointestinal, gynecologic and other malignancies, often before the age of 50. Current guidelines recommend prophylactic gynecologic surgery to manage inherited cancers for female mutation carriers. Data is lacking on women's quality of life following surgery. In this pilot study, we explored how women described their quality of life post-prophylactic gynecologic surgery and the factors that affected post-surgery experiences. A qualitative interview study was the chosen design. Ten female Lynch syndrome mutation carriers were interviewed by phone. Interviews were transcribed and analysed for themes relating to quality of life post-surgery using content analysis and constant comparison. Women largely reported doing well since their surgeries, though all described deleterious impacts on quality of life. Positive impacts of surgery included a reduction in cancer worry and an increase in healthy lifestyle behaviors, while negative impacts due to the sudden onset of menopause and impact on sexual function were common. Pre-surgical knowledge, drug and topical therapies, and post-surgical support all contributed to a positive quality of life. This small pilot study revealed increased endocrine symptoms and a negative impact on sexual health following prophylactic gynecological surgery. Women who were informed of potential symptoms pre-surgery coped better with surgical outcomes, as did women using some form of HRT. All women experienced reduced cancer worry post-surgery. Findings highlight areas for discussion in pre-operative settings (e.g., sexual health), as well as the need for better follow-up support post-surgery.

Entities:  

Keywords:  Carrier; Gynecologic cancer; Lynch syndrome; Qualitative; Quality of life

Mesh:

Year:  2018        PMID: 28551770     DOI: 10.1007/s10689-017-9997-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  33 in total

Review 1.  Qualitative research in health care. Analysing qualitative data.

Authors:  C Pope; S Ziebland; N Mays
Journal:  BMJ       Date:  2000-01-08

2.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

3.  Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study.

Authors:  Lori A Brotto; Nadia Branco; Cara Dunkley; Mary McCullum; Jessica N McAlpine
Journal:  J Obstet Gynaecol Can       Date:  2012-02

4.  A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Authors:  Carolyn Y Fang; Carol Cherry; Karthik Devarajan; Tianyu Li; John Malick; Mary B Daly
Journal:  Gynecol Oncol       Date:  2009-01-13       Impact factor: 5.482

5.  Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.

Authors:  K Tiller; B Meiser; L Gould; K Tucker; T Dudding; J Franklin; M Friedlander; L Andrews
Journal:  Psychooncology       Date:  2005-04       Impact factor: 3.894

6.  Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome.

Authors:  Kathleen M Schmeler; Molly S Daniels; Pamela T Soliman; Russell R Broaddus; Michael T Deavers; Thuy M Vu; George J Chang; Karen H Lu
Journal:  Obstet Gynecol       Date:  2010-02       Impact factor: 7.661

Review 7.  Prophylactic oophorectomy in premenopausal women and long-term health.

Authors:  Lynne T Shuster; Bobbie S Gostout; Brandon R Grossardt; Walter A Rocca
Journal:  Menopause Int       Date:  2008-09

8.  Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy.

Authors:  Paige E Tucker; Max K Bulsara; Stuart G Salfinger; Jason Jit-Sun Tan; Helena Green; Paul A Cohen
Journal:  Gynecol Oncol       Date:  2015-11-03       Impact factor: 5.482

9.  An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.

Authors:  Kate Brain; Clare Gravell; Elizabeth France; Alison Fiander; Jonathon Gray
Journal:  Gynecol Oncol       Date:  2004-03       Impact factor: 5.482

10.  Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Kathy Watkins; Sabrina Alani; Lesa Dawson
Journal:  Hered Cancer Clin Pract       Date:  2015-03-19       Impact factor: 2.857

View more
  5 in total

1.  Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.

Authors:  Sarah Knerr; Boya Guo; Kathleen F Mittendorf; Heather Spencer Feigelson; Marian J Gilmore; Gail P Jarvik; Tia L Kauffman; Erin Keast; Frances L Lynch; Kristin R Muessig; Sonia Okuyama; David L Veenstra; Jamilyn M Zepp; Katrina A B Goddard; Beth Devine
Journal:  Cancer       Date:  2022-06-09       Impact factor: 6.921

2.  Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome.

Authors:  Kaitlin M McGarragle; Melyssa Aronson; Kara Semotiuk; Spring Holter; Crystal J Hare; Sarah E Ferguson; Zane Cohen; Tae L Hart
Journal:  Hered Cancer Clin Pract       Date:  2019-08-13       Impact factor: 2.857

3.  Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study.

Authors:  Mari H Kalamo; J U Mäenpää; T T Seppälä; J P Mecklin; H Huhtala; K Sorvettula; K Pylvänäinen; S Staff
Journal:  Fam Cancer       Date:  2020-01-29       Impact factor: 2.375

4.  Associations Between Personality Traits, Perceived Stress and Depressive Symptoms in Gynecological Cancer Patients Characterized by the Short and Long Allele Variant of the 5-HTTLPR Genotype: Preliminary Results.

Authors:  Salvatore Iuso; Lucia Monacis; Luigi Nappi; Stefania Malerba; Giovanna D'Andrea; Mario Altamura; Maurizio Margaglione; Antonello Bellomo; Annamaria Petito
Journal:  Clin Neuropsychiatry       Date:  2022-06

5.  Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.

Authors:  Toni T Seppälä; Mev Dominguez-Valentin; Emma J Crosbie; Christoph Engel; Stefan Aretz; Finlay Macrae; Ingrid Winship; Gabriel Capella; Huw Thomas; Eivind Hovig; Maartje Nielsen; Rolf H Sijmons; Lucio Bertario; Bernardo Bonanni; Maria G Tibiletti; Giulia M Cavestro; Miriam Mints; Nathan Gluck; Lior Katz; Karl Heinimann; Carlos A Vaccaro; Kate Green; Fiona Lalloo; James Hill; Wolff Schmiegel; Deepak Vangala; Claudia Perne; Hans-Georg Strauß; Johanna Tecklenburg; Elke Holinski-Feder; Verena Steinke-Lange; Jukka-Pekka Mecklin; John-Paul Plazzer; Marta Pineda; Matilde Navarro; Joan B Vida; Revital Kariv; Guy Rosner; Tamara A Piñero; Walter Pavicic; Pablo Kalfayan; Sanne W Ten Broeke; Mark A Jenkins; Lone Sunde; Inge Bernstein; John Burn; Marc Greenblatt; Wouter H de Vos Tot Nederveen Cappel; Adriana Della Valle; Francisco Lopez-Koestner; Karin Alvarez; Reinhard Büttner; Heike Görgens; Monika Morak; Stefanie Holzapfel; Robert Hüneburg; Magnus von Knebel Doeberitz; Markus Loeffler; Silke Redler; Jürgen Weitz; Kirsi Pylvänäinen; Laura Renkonen-Sinisalo; Anna Lepistö; John L Hopper; Aung K Win; Noralane M Lindor; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; Jane C Figueiredo; Stephen N Thibodeau; Christina Therkildsen; Karin A W Wadt; Marian J E Mourits; Zohreh Ketabi; Oliver G Denton; Einar A Rødland; Hans Vasen; Florencia Neffa; Patricia Esperon; Douglas Tjandra; Gabriela Möslein; Erik Rokkones; Julian R Sampson; D G Evans; Pål Møller
Journal:  Eur J Cancer       Date:  2021-03-17       Impact factor: 9.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.